Orlando Health Digestive Health Institute Center for Advanced Endoscopy, Research and Education opens
Press releases may be edited for formatting or style | February 08, 2022
Endoscopy
ORLANDO, Fla., Feb. 7, 2022 /PRNewswire/ -- Phase one of the new Orlando Health Digestive Health Institute Center for Advanced Endoscopy, Research and Education (CARE) officially opened today. Located on the downtown Orlando campus adjacent to Orlando Health Orlando Regional Medical Center, the center features technologically advanced procedure rooms, preoperative and recovery bays and support space for patients and staff. Phase two of the center, which will increase square footage creating additional space for patient care and staff, will open in the summer of 2022. The highly specialized gastrointestinal diagnostic and treatment center will serve as the flagship destination of the Orlando Health Digestive Health Institute, one of the most comprehensive gastrointestinal programs in the southeastern United States.
"Our physicians and advanced practitioners use the best traditions of clinical medicine, apply cutting-edge innovations, and incorporate the most current research findings to provide comprehensive, compassionate care for each patient," said Shyam S. Varadarajulu, MD, president, Orlando Health Digestive Health Institute. "We are excited to offer technology patients will find only at our program, treatment options that are available at only a few facilities around the country and participate in cutting-edge clinical trials that leads to innovation. We have designed a truly unique program."
The Institute, which provides advanced medical care for general, extremely complex, and often rare digestive and liver disorders, was designed and developed by four internationally recognized experts, all of whom are board certified in gastroenterology: Dr. Varadarajulu, who specializes in complex digestive disorders, has authored more than 300 research publications and has served in visiting professorships around the world; Ji Young Bang, MD, is internationally recognized for her research in interventional endoscopy and has conducted 15 randomized clinical trials to date, winning numerous awards at all major national and internal conferences for her research; Robert H. Hawes, MD, former President of the American Society for Gastrointestinal Endoscopy, specializes in advanced endoscopy with particular interest in pancreatobiliary diseases and gastrointestinal oncology; and Udayakumar Navaneethan, MD, is a leading international expert on inflammatory bowel disease (IBD) who is currently the principal investigator for multiple IBD-related clinical trials and studies.
"Our physicians and advanced practitioners use the best traditions of clinical medicine, apply cutting-edge innovations, and incorporate the most current research findings to provide comprehensive, compassionate care for each patient," said Shyam S. Varadarajulu, MD, president, Orlando Health Digestive Health Institute. "We are excited to offer technology patients will find only at our program, treatment options that are available at only a few facilities around the country and participate in cutting-edge clinical trials that leads to innovation. We have designed a truly unique program."
The Institute, which provides advanced medical care for general, extremely complex, and often rare digestive and liver disorders, was designed and developed by four internationally recognized experts, all of whom are board certified in gastroenterology: Dr. Varadarajulu, who specializes in complex digestive disorders, has authored more than 300 research publications and has served in visiting professorships around the world; Ji Young Bang, MD, is internationally recognized for her research in interventional endoscopy and has conducted 15 randomized clinical trials to date, winning numerous awards at all major national and internal conferences for her research; Robert H. Hawes, MD, former President of the American Society for Gastrointestinal Endoscopy, specializes in advanced endoscopy with particular interest in pancreatobiliary diseases and gastrointestinal oncology; and Udayakumar Navaneethan, MD, is a leading international expert on inflammatory bowel disease (IBD) who is currently the principal investigator for multiple IBD-related clinical trials and studies.
You Must Be Logged In To Post A CommentRegisterRegistration is Free and Easy. Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace. Register Now! |
|
